Yellow fever vaccination for immunocompromised travellers: unjustified vaccination hesitancy?

被引：12
作者：
de Jong, Wesley [1 ]
de Man, Rob A. [2 ]
Dalm, Virgil A. S. H. [3 ,4 ]
Reusken, Chantal B. E. M. [1 ,7 ]
Goeijenbier, Marco [1 ,5 ]
van Gorp, Eric C. M. [1 ,6 ]
机构：
[1] Erasmus MC, Dept Virosci, NL-3015 GD Rotterdam, Netherlands
[2] Erasmus MC, Dept Gastroenterol & Liver Dis, NL-3015 GD Rotterdam, Netherlands
[3] Erasmus MC, Dept Internal Med, Div Clin Immunol, NL-3015 GD Rotterdam, Netherlands
[4] Erasmus MC, Dept Immunol, NL-3015 GD Rotterdam, Netherlands
[5] Erasmus MC, Dept Internal Med, NL-3015 GD Rotterdam, Netherlands
[6] Erasmus MC, Dept Infect Dis, NL-3015 GD Rotterdam, Netherlands
[7] Natl Inst Publ Hlth & Environm, Netherlands Ctr Infect Dis Control, NL-3721 GM Bilthoven, Netherlands
来源：
JOURNAL OF TRAVEL MEDICINE | 2019年 / 26卷 / 06期
关键词：
SAFETY; 17D;
D O I：
10.1093/jtm/taz015
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 10 条
  • [1] Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter study
    Azevedo, L. S.
    Lasmar, E. P.
    Contieri, F. L. C.
    Boin, I.
    Percegona, L.
    Saber, L. T. S.
    Selistre, L. S.
    Netto, M. V. P.
    Moreira, M. C. V.
    Carvalho, R. M.
    Bruno, R. M.
    Ferreira, T. C. A.
    David-Neto, E.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2012, 14 (03) : 237 - 241
  • [2] Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports
    Croce, Evelina
    Hatz, Christoph
    Jonker, Emile F.
    Visser, L. G.
    Jaeger, Veronika K.
    Buhler, Silja
    [J]. VACCINE, 2017, 35 (09) : 1216 - 1226
  • [3] Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, Dengue virus, and Yellow fever virus by real-time reverse transcription-PCR
    Drosten, C
    Göttig, S
    Schilling, S
    Asper, M
    Panning, M
    Schmitz, H
    Günther, S
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (07) : 2323 - 2330
  • [4] Kotton C, 2017, CDC YELLOW BOOK
  • [5] Monath TP, 2018, UPTODATE YELLOW FEVE
  • [6] Safety of the Yellow Fever Vaccine: A Retrospective Study
    Nordin, James D.
    Parker, Emily D.
    Vazquez-Benitez, Gabriela
    Kharbanda, Elyse O.
    Naleway, Allison
    Marcy, S. Michael
    Molitor, Beth
    Kuckler, Leslie
    Baggs, James
    [J]. JOURNAL OF TRAVEL MEDICINE, 2013, 20 (06) : 368 - 373
  • [7] Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: Systematic review
    Thomas, Roger E.
    Lorenzetti, Diane L.
    Spragins, Wendy
    Jackson, Dave
    Williamson, Tyler
    [J]. VACCINE, 2011, 29 (28) : 4544 - 4555
  • [8] The Immunosuppressed Traveler
    Visser, L. G.
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2012, 26 (03) : 609 - +
  • [9] 17D yellow fever vaccine elicits comparable long-term immune responses in healthy individuals and immune-compromised patients
    Wieten, R. W.
    Goorhuis, A.
    Jonker, E. F. F.
    de Bree, G. J.
    de Visser, A. W.
    van Genderen, P. J. J.
    Remmerswaal, E. B. M.
    ten Berge, I. J. M.
    Visser, L. G.
    Grobusch, M. P.
    van Leeuwen, E. M. M.
    [J]. JOURNAL OF INFECTION, 2016, 72 (06) : 713 - 722
  • [10] World Health Organization, 2018, WHO YELL FEV
1